BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37203893)

  • 1. Multidrug Resistant Escherichia coli among Urinary Samples of Patients with Urinary Tract Infection in the Microbiology Department of a Tertiary Care Center: A Descriptive Cross-Sectional Study.
    Chaudhary R; Pradhan M; Bhatta S; Shrestha S; Adhikari N; Singh YI
    JNMA J Nepal Med Assoc; 2023 May; 61(261):437-441. PubMed ID: 37203893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence Of Blaoxa-48, Blavim, And Blashv Genes In Klebsiella Pneumoniae And Escherichia Coli Isolated From Urinary Tract Infections: Microbiological And Epidemiological Analysis.
    Abdallah M; Haroun S; Tahoun A; Hegazy YM; Eldomany R
    J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S294-S304. PubMed ID: 37482876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Characterization of Multidrug-resistant Escherichia Coli with Special Reference to Extended-spectrum-beta-lactamases and Metallo-beta-lactamases in a Tertiary Care Center.
    Shrestha B; Shrestha S; Mishra SK; Kattel HP; Tada T; Ohara H; Kirikae T; Rijal BP; Sherchand JB; Pokhrel BM
    JNMA J Nepal Med Assoc; 2015; 53(198):89-95. PubMed ID: 26994027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection of Uropathogenic Escherichia coli among COVID-19 Patients Admitted to a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Basnet A; Chand AB; Shrestha LB; Pokhrel N; Karki L; Shrestha SKD; Tamang B; Shrestha MR; Dulal M; Rai JR
    JNMA J Nepal Med Assoc; 2022 Mar; 60(247):294-298. PubMed ID: 35633253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Prevalence of Extended Spectrum β-Lactamase Producing Uropathogenic Escherichia coli Among Patients with Diabetes from a Tertiary Care Hospital of Kathmandu, Nepal.
    Nayaju T; Upreti MK; Ghimire A; Shrestha B; Maharjan B; Joshi RD; Lekhak B; Thapa Shrestha U
    Am J Trop Med Hyg; 2021 Aug; 105(5):1347-1355. PubMed ID: 34424860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
    Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic
    Neamati F; Khorshidi A; Moniri R; Hosseini Tafreshi SA
    Microb Drug Resist; 2020 Jan; 26(1):60-70. PubMed ID: 31526226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metallo-β-lactamases and AmpC production among Escherichia coli strains isolated from hemodialysis patients with urinary tract infection.
    Bahramian A; Khoshnood S; Hashemi N; Moradi M; Karimi-Yazdi M; Jalallou N; Saki M
    Mol Biol Rep; 2021 Dec; 48(12):7883-7892. PubMed ID: 34657270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
    Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AmpC and extended spectrum beta-lactamases production among urinary isolates from a tertiary care hospital in Lalitpur, Nepal.
    Rai S; Pant ND; Bhandari R; Giri A; Parajuli R; Aryal M; Amatya J; Sharma VK
    BMC Res Notes; 2017 Sep; 10(1):467. PubMed ID: 28882177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-onset extended-spectrum β-lactamase producing Escherichia coli in urinary tract infections in children from 2015 to 2016: Prevalence, risk factors, and resistances.
    Pérez Heras I; Sanchez-Gomez JC; Beneyto-Martin P; Ruano-de-Pablo L; Losada-Pinedo B
    Medicine (Baltimore); 2017 Dec; 96(50):e8571. PubMed ID: 29390257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characterization of antimicrobial resistant
    Onanuga A; Mahindroo J; Singh S; Taneja N
    Pan Afr Med J; 2019; 34():144. PubMed ID: 32010423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
    Marković T; Jeinić L; Smitran A; Petković M
    Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela.
    Guzmán M; Salazar E; Cordero V; Castro A; Villanueva A; Rodulfo H; De Donato M
    Biomedica; 2019 May; 39(s1):96-107. PubMed ID: 31529852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance patterns of pediatric community-acquired urinary tract infections in a tertiary care center in Jeddah, Saudi Arabia.
    Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alshehry MA; Alnajjar AA
    J Infect Dev Ctries; 2023 Oct; 17(10):1430-1435. PubMed ID: 37956373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.